Eikon Therapeutics, Inc. (Nasdaq: EIKN), a clinical-stage biopharmaceutical company, announced it will be added to the Russell 3000® Index following ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE